Publicaciones | Information systems RSS feed for this section

Migraine. The promotion of prescription drugs directly to the public is not allowed in the European Union. But see the Ajovy case in Spain: direct-to-consumer news, the blurred margin between propaganda and information.

15 Mar

It seems that Teva’s commercial strategy includes promoting fremanezumab (Ajovy) to the general public (direct-to-consumer).  Vall d’Hebron Hospital (Barcelona, Spain) supports and presents as a novelty something that “offers nothing new”.  Such promotion is clearly prohibited by Spanish and European legislation.  It is also accompanied by an incredible and constant “apparatus” of pressure on those [...]

The European Alliance for Responsible R&D and Affordable Medicines transparency of clinical trials and good governance should be included in the EMA (European Medicines Agency) extended mandate

13 Sep

In occasion of the ongoing trilogues on the European Medicines Agency (EMA) extended mandate, Members of the European Alliance for Responsible R&D and Affordable Medicines urge the Council to ensure the new Regulation enhances clinical trial transparency and upholds good governance.    As explained in a letter published today, it is crucial that information on [...]

Sacred secrets broken. Threats to the confidentiality of medical records. The case of Osabide, the centralized data base of Osakidetza (Basque Health Service) in Spain

25 Mar

The Basque Health Service, Osakidetza, established in 2003 a centralized data base, Osabide, with two millions medical records in full without asking permission or even notifying patients or the public (in some cases against the written opposition of a few patients who knew about the initiative). Two general practitioners who rejected Osabide and prepared a [...]